Ifreke Udodong, | |
1310 Southern Ave Se, Washington, DC 20032-4623 | |
(202) 574-6000 | |
Not Available |
Full Name | Ifreke Udodong |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Adult Health |
Location | 1310 Southern Ave Se, Washington, District Of Columbia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487180972 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Ifreke Udodong, 1310 Southern Ave Se, Washington, DC 20032-4623 Ph: (202) 574-6000 | Ifreke Udodong, 1310 Southern Ave Se, Washington, DC 20032-4623 Ph: (202) 574-6000 |
News Archive
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that results from a pre-clinical study showed significant improvement in the delivery and half life of Å6, a proprietary peptide treatment for ovarian cancer currently in Phase 2 development by Angstrom Pharmaceuticals. Specifically, the incorporation of NexACT® enabled the dose of Å6 to be cut by half, or from twice per day to once per day delivered subcutaneously, while achieving the same level of efficacy in the mouse lung metastasis model.
Although the Americans with Disabilities Act (ADA) has helped increase awareness of barriers faced by people with disabilities, and advances in science and engineering have led to better assistive technologies that make it easier for individuals to lead productive, independent lives, outdated regulations too often impede access to health care coverage and assistive devices for many who need them, says a new report by the Institute of Medicine.
CAQH® announced today that Aetna and WellPoint, together serving over 50 million members, are the first national health plans to earn certification for electronically exchanging administrative data using the CAQH Committee on Operating Rules for Information Exchange® (CORE) Phase II rules.
UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling (IFN).
› Verified 1 days ago
Mrs. Lori Ann Cook, RN,MS,CS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-745-8691 | |
Elizabeth Bettini, Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-475-1211 | |
Ms. Dianne Behme Carlson, APRN CLINICAL NURSE Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 5247 Wisconsin Ave Nw, Suite 2, Washington, DC 20015 Phone: 202-256-3601 | |
Mrs. Yasmin Schorr, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 501 School St Sw Ste 200, Washington, DC 20024 Phone: 202-955-8355 | |
Ms. Virginia Carter Gebus, RN,MSN,APN,CNSN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 111 Michigan Ave Nw, Department Of Gastroenterology, Washington, DC 20010 Phone: 202-884-4125 Fax: 202-884-4156 | |
Colleen Iler, DNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-1518 Fax: 202-476-5222 | |
June K Amling, MSN, RN, CNS, CCRN Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Advanced Practice Nursing, Washington, DC 20010 Phone: 202-476-5000 Fax: 202-476-4528 |